Hmos - OmicsDI

Show results for

Unknown (398)
Genomics (78)
Transcriptomics (22)
Proteomics (11)
Genomic (3)
Multiomics (2)
Metabolomics (2)

Organisms

Homo sapiens (8)
Bifidobacterium longum subsp. infantis (6)
Mus musculus (6)
Schizophyllum commune H4-8 (6)
Mycobacterium tuberculosis SP7 (6)
Salmonella enterica subsp. enterica serovar Typhimurium str. T000240 (6)
Oryza sativa Japonica Group (6)
Rabbit calicivirus (6)
Crotalus durissus terrificus (6)
Eriocheir sinensis (6)
Candidatus Endoriftia persephonae (6)
Mycobacterium tuberculosis SP10 (6)
Mycobacterium tuberculosis SP13 (6)
Cotesia typhae (6)
Mycobacterium tuberculosis SP22 (6)
Cepaea nemoralis (6)
Geobacillus kaustophilus HTA426 (6)
Enterobacter ludwigii (6)
Trichoderma asperellum CBS 433.97 (6)
Corynebacterium diphtheriae bv. mitis str. ISS 3319 (6)
Nakaseomyces glabratus (6)
Olea europaea (6)
Mumps virus strain Enders (6)
Chlamydomonas reinhardtii (6)
Deinococcus deserti VCD115 (6)
Lama (6)
Planorbella pilsbryi (6)
Bacteroides fragilis NCTC 9343 (2)
Bifidobacterium breve UCC2003 (2)
Bifidobacterium catenulatum subsp. kashiwanohense (1)

Organisms

Homo sapiens (7)
Bifidobacterium longum subsp. infantis (6)
Mus musculus (6)
mouse gut metagenome (2)
human gut metagenome (2)
human metagenome (2)
Bacteroides fragilis NCTC 9343 (1)
Bifidobacterium breve UCC2003 (1)
Streptococcus agalactiae (1)
feces metagenome (1)

Repository

ENA (77)
geo (21)
pride (6)
MassIVE (4)
dbGaP (3)
biostudies-arrayexpress (2)
MetaboLights (2)
jPOST (1)

Tissue

Midbrain (1)
Primary cell line cell (1)
Gut (1)

Technology Type

Mass Spectrometry (6)
Bottom-up proteomics (2)
Shotgun proteomics (2)
NMR spectroscopy (1)
Mass spectrometry (1)
Gel-based experiment (1)
All-ion fragmentation (1)
Data-independent acquisition (1)

Instrument Platform

Q Exactive (2)
Orbitrap Exploris 240 (1)
Q Exactive Plus (1)
Liquid Chromatography MS - negative - direct infusion (1)
Liquid Chromatography MS - positive - direct infusion (1)
Nuclear Magnetic Resonance (NMR) - (1)

Publication Date

2026 (9)
2024 (7)
2020 (4)
2012 (2)
2011 (2)
2023 (2)
2022 (2)
2019 (2)
2017 (1)
2025 (1)
2021 (1)
2016 (1)

CHEBI ID

CHEBI:35693 (1)
CHEBI:29805 (1)
CHEBI:86394 (1)
CHEBI:48999 (1)
CHEBI:51057 (1)
CHEBI:18401 (1)
CHEBI:48942 (1)
CHEBI:17968 (1)
CHEBI:17272 (1)
CHEBI:32544 (1)
CHEBI:17836 (1)
CHEBI:31011 (1)
CHEBI:24996 (1)
CHEBI:132950 (1)
CHEBI:17790 (1)
CHEBI:18139 (1)
CHEBI:15740 (1)
CHEBI:48944 (1)
CHEBI:29987 (1)
CHEBI:30089 (1)
CHEBI:18186 (1)
CHEBI:17234 (1)
CHEBI:28831 (1)
CHEBI:16830 (1)
CHEBI:17847 (1)
CHEBI:17170 (1)
CHEBI:16236 (1)
CHEBI:17824 (1)
CHEBI:32980 (1)
CHEBI:16811 (1)

Metabolite Name

PC(22:2(13Z,16Z)/LTE4) (1)
Beta-Alanine, N-(N-(2-((2,2-dimethyl-1,3-dioxolan-4-yl)methoxy)-2-oxo-1-(phenylmethyl)ethyl)-L-phenylalanyl)- (1)
PI(22:5(4Z,7Z,10Z,13Z,16Z)/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)) (1)
PGP(a-15:0/TXB2) (1)
PI(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)) (1)
PC(18:1(11Z)/LTE4) (1)
PS(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/18:4(6Z,9Z,12Z,15Z)) (1)
PI(LTE4/16:0) (1)
PIP(20:4(5Z,8Z,11Z,14Z)/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)) (1)
PI(18:0/LTE4) (1)
2,4-Bis(1-decyloxyethyl)deuteroporphyrinyl-6,7-bisaspartic acid (1)
CDP-DG(PGF1alpha/i-22:0) (1)
PG(20:3(5Z,8Z,11Z)/PGJ2) (1)
PG(a-25:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)) (1)
PG(a-17:0/PGF2alpha) (1)
Lipid IVA (1)
Magnoflorine (1)
PGP(a-15:0/PGF2alpha) (1)
PI(PGJ2/22:5(4Z,7Z,10Z,13Z,16Z)) (1)
PI(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/18:0) (1)
[Sar9,Met(O2)11]-SUBSTANCE P (1)
PIP(22:3(10Z,13Z,16Z)/18:2(10E,12Z)+=O(9)) (1)
SM(d16:2(4E,8Z)/LTE4) (1)
PGP(i-22:0/PGE2) (1)
PS(14:1(9Z)/PGE1) (1)
SCHEMBL13960539 (1)
Hemopressin (1)
CDP-DG(18:2(9Z,11Z)/LTE4) (1)
2-Methyl-8-(phenylmethoxy)imidazo[1,2-a]pyridine-3-acetonitrile (1)
N-[(5-{2-[(6R)-2-Amino-4-oxo-3,4,5,6,7,8-hexahydropyrido[2,3-D]pyrimidin-6-YL]ethyl}-2-thienyl)carbonyl]-L-glutamic acid (1)

First Public Date

2024 (18)
2026 (15)
2025 (12)
2023 (6)
2022 (5)
2020 (5)
2019 (5)
2021 (3)
2016 (3)
2017 (2)
2014 (2)
2018 (1)

Classification

bacteria (2)

Study type

Transcription profiling by array (2)

Release Date

2021 (53)
2024 (52)
2023 (51)
2022 (51)
2025 (45)
2020 (45)
2018 (24)
2019 (18)
2017 (15)
2026 (8)
2015 (8)
2012 (7)
2016 (7)
2013 (7)
2011 (3)
2014 (2)
2010 (2)
2009 (1)
2006 (1)

Lab affiliation

McGill University Department of Pharmacology and Therapeutics Centre de Recherche en Biologie Structurale (1)
DTU BIOENGINEERING Department of Biotechnology and Biomedicine PCET-Protein Glycoscience and Biotechnology Technical University of Denmark 2800 Kgs. Lyngby (1)
Proteomics Core, DTU Bioengineering, Technical University of Denmark (DTU), Lyngby, Denmark (1)
Associate Professor, Dept. of Food Science Adjunct Associate Professor, Dept. of Microbiology University of Massachusetts Amherst Adjunct Associate Professor, Dept. of Microbiology & Physiological Systems University of Massachusetts Medical School selalab.org 413.545.1010 (1)
Chemistry Department, University of California, Davis, USA (1)
Wageningen University (1)

Previous page
1 / 52
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 52
Next page

Sort by:

Relevance

Page size

Human Milk Oligosaccharides (HMOS): Structure, Function, and Enzyme-Catalyzed Synthesis.

Not available

S-EPMC9235823 | biostudies-literature

Human milk oligosaccharides differentially support gut barrier integrity and enhance Th1 and Th17 cell effector responses in vitro.

Not available

S-EPMC10950922 | biostudies-literature

To understand which glycan-related genes are involved in the recognition, signaling, and binding of nutrients (HMOs)

Dr. Lebrilla's lab is working on another set of transcriptomics experiments which will measure whether HMO (human milk oligosacharides) elicit a differential response on Caco2 in the presence of B.infantis. They wish to supplement the data obtained with the Illumina platform with glycan-related expr...

ORGANISM(S): Homo sapiens

2011-06-14 | E-GEOD-29934 | biostudies-arrayexpress

null

BIG-Syc continuous fermentations on HMOs

PRJEB72539 | ENA

human metagenome

Effects of HMOs on the microbiota composition

PRJNA478195 | ENA

null

BIG-Syc sequential batch fermentations on HMOs

PRJEB72560 | ENA

HMOs Exert Marked Bifidogenic Effects on Children's Gut Microbiota Ex Vivo, Due to Age-Related Bifidobacterium Species Composition.